πŸ‡ΊπŸ‡Έ FDA
Patent

US 12162821

Treatment of cataplexy

granted A61KA61K31/27A61K31/325

Quick answer

US patent 12162821 (Treatment of cataplexy) held by AXSOME MALTA LTD. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/27, A61K31/325, A61K45/06, A61K9/0053